This study demonstrates that FCGR2A, GSDMB, MIR330, MED1, and SQSTM1 are the candidate biomarkers for the progression of HF after MI, and the combination of GSDMB and SQSTM1 has the highest predictive value. This evidence concerns the gene MIR330 and hydrops fetalis.